Skip to main content

Table 4 Multivariate analyses of clinical factors affecting one year virologic response

From: Comparison of the long-term efficacy between entecavir and tenofovir in treatment- naïve chronic hepatitis B patients

Factors RR 95% CI P
Disease status (CHB/LC) 0.559 0.205–1.521 0.255
IVR-3 (+/−) 6.214 2.500–15.443 <0.001
HBeAg (−/+) 3.184 0.977–10.377 0.055
Serum HBV DNA level (log10 IU/mL) 0.605 0.357–1.023 0.061
  1. RR, relative risk, 95% CI 95% confidence interval, CHB chronic hepatitis B, HBeAg hepatitis B e antigen, HBV hepatitis B virus, IVR-3 initial virologic response at 3 months, LC liver cirrhosis